Advantex Marketing I (ATXMF) 0.0010 $ATXMF Advantex

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Advantex Marketing I (ATXMF) 0.0010 $ATXMF

Advantex Announces Fiscal 2016 Third Quarter Results
Marketwire Canada - Mon May 30, 4:53PM CDT
EBITDA (1) of $1.1 million after restructuring of Fiscal year 2015

Advantex Announces Extension of Its Agreement With CIBC
Marketwired - Thu Apr 14, 1:32PM CDT
Advantex Marketing International Inc. (CSE: ADX), a specialist in marketing loyalty-reward programs, today announced that it has agreed with Canadian Imperial Bank of Commerce ("CIBC" on an extension until December 31, 2016 of their agreement which was due to expire on September 30, 2016.

Advantex Announces Fiscal 2016 First Quarter Results
Marketwired - Thu Nov 26, 3:42PM CST
Advantex Marketing International Inc. (CSE: ADX), a specialist in marketing loyalty-reward programs, announced its results for the three months ended September 30, 2015.

Advantex Updates Business Prospects and Announces Fiscal 2015 Results
Marketwired - Wed Oct 28, 4:18PM CDT
Advantex Marketing International Inc. (CSE: ADX), a specialist in marketing loyalty- reward programs, announced its results for Fiscal year ended June 30, 2015.

Advantex Renews $8.5m Credit Facility
Marketwired - Wed Oct 07, 5:57PM CDT
Advantex Marketing International Inc. (CSE: ADX), a specialist in marketing loyalty-reward programs, has renewed its credit facility with Accord Financial Inc. for one year to December 2016.

Advantex Reports Financial Results for the Third Quarter of Fiscal 2015
Marketwire Canada - Fri May 29, 4:15PM CDT
Advantex Marketing International Inc. (CSE:ADX), a specialist in loyalty marketing programs, today reported a net loss of $2,582,155 for the three months ended March 31, 2015, compared with net loss of $396,066 for the same period a year earlier.

Advantex Reports Financial Results for the Second Quarter of Fiscal 2015
Marketwired - Mon Mar 02, 3:06PM CST
Advantex Marketing International Inc. (CSE: ADX), a specialist in marketing loyalty-reward programs, today reported a net loss of $144,079 for the three months ended December 31, 2014, compared with net income of $74,983 for the same period a year earlier.

Advantex Adapts to New Economic Realities
Marketwired - Wed Jan 28, 3:05PM CST
Advantex Marketing International Inc. (CSE: ADX), a specialist in marketing loyalty-reward programs, is taking a number of pre-emptive measures in response to recent developments in the Canadian marketplace.

Advantex Returns to Profitability in First Quarter of Fiscal 2015
Marketwired - Fri Nov 21, 7:31AM CST
Advantex Marketing International Inc. (CSE: ADX), a specialist in marketing loyalty-reward programs, today reported net income of $19,807 for the three months ended September 30, 2014.

Advantex and Aimia Renew Aeroplan Partnership
Marketwired - Fri Nov 07, 10:58AM CST
Advantex Marketing International Inc. (CSE: ADX), a specialist in marketing loyalty-reward programs, and Aimia Canada Inc., a global leader in loyalty management and owner of the Aeroplan program, announced today the renewal of a multi-year agreement.

Advantex Announces Update on Its Partnership With Aeroplan
Marketwired - Fri Oct 31, 5:15PM CDT
Advantex Marketing International Inc. ("Advantex" (CSE: ADX), a leading specialist in the marketing services industry, announced today that it has agreed with Aimia Canada Inc. ("Aeroplan" to further extend to November 30th, 2014 the extension, due to expire on October 31, 2014, to their existing agreement.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Palm Beach Royals Boost Pickleball's Popularity Surge

Updated Category News Views 21

A New Era for Pickleball in Palm Beach It might be time to re-evaluate pickleball if you weren't paying attention before. The Palm Beach Royals have wrapped up their first Major League Pickleball season with a bang, marking a pivotal year for the sport. This underdog tale of graft and grit is carving out a new chapter in the world of sport. Record-Breaking Season for MLP...

Continue Reading
Hilarity and Hassles in NYC Co-op Life Exposed in New Book

Updated Category News Views 17

Co-op Living: Not All It's Cracked Up to Be Let me tell you something, buying a co-op in New York City isn't just signing on the dotted line and moving in. Nope, it's a whole damn production. Jeff Namian's book, Thin Walls/Thick Ears, lays it all out with a mix of humor and hard truths, painting a stark picture of NYC co-op living. He's not just telling his own story of...

Continue Reading
Aging at Home: The Real Costs and Obstacles Ahead

Updated Category News Views 9

Facing the Realities of Aging In Place Alright, let's talk straight. Everyone dreams of staying home in their twilight years, kicking back in their favorite chair with family nearby. But the harsh truth? That comfort comes with a price tag. According to Northwestern Mutual's 2026 Planning & Progress Study, up to 83% of Boomers+ and most other generations fancy the idea of...

Continue Reading
Travelers Turn to Direct Booking Amid Cost Surge

Updated Category News Views 18

Getting Ahead of the Travel Expense Game Rising fees and tighter budgets haven't persuaded holiday travelers to abandon their plans. Instead, they’re sharpening their axes, looking for clearer paths to their vacation goals without slicing off an arm and a leg. With the cost of travel climbing faster than a runaway elevator, folks are getting smart about where their...

Continue Reading
TRIMAX Poised to Meet AI-Driven Power Challenges

Updated Category News Views 12

TRIMAX's Bold Move into AI-Powered Infrastructure It feels like we're standing on the cusp of a seismic shift, folks. Artificial intelligence isn't just another buzzword anymore—it's a juggernaut reshaping our digital world. TRIMAX Power Systems is gearing up to ride this wave, with its eyes set on capturing a chunk of the booming demand for fast-deployable power...

Continue Reading
OMLYCLO Shakes Up U.S. Biologic Market as Key Player

Updated Category News Views 14

Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...

Continue Reading
Dan Brown Joins Guidewire: Big Moves in P&C Software

Updated Category News Views 17

Turning the Insurance World on Its Head Just when you think the enterprise software scene is getting predictable, along comes a bit of news to shake things up. Guidewire, a name known in the P&C insurance software world, has roped in a veteran—Dan Brown—who's got more than a quarter-century under his belt shaping product strategies. It’s not just another suit...

Continue Reading
ProClad Unveils Innovative Hybrid 2.0 Cookware

Updated Category News Views 14

Revolutionizing Cookware: The Launch of Hybrid 2.0 Today, everyone's buzzing about ProClad's big reveal—the Hybrid 2.0 Pan. Now, before you roll those skeptical eyes, hear me out. This isn’t your average bit of kitchen fluff; it’s a heavyweight contender stepping into the everyday cooking ring. What they've done here is combine the muscle of stainless steel searing...

Continue Reading
GL1F Crypto: A Breakthrough in On-Chain AI for Crypto

Updated Category News Views 9

The Dawn of On-Chain Machine Learning In a world where crypto folks often tout decentralization like it’s the holy grail, GenesisL1 is throwing open the doors to a new kind of crypto playground with GL1F Crypto. A decentralized on-chain AI studio? Sounds like sci-fi, but here we are—hands on the precipice of democratized machine learning in your browser. A Lab in...

Continue Reading
Metropolitan Dermatology's Strategic Expansion into Barnegat

Updated Category News Views 14

Diving into Barnegat's Dermatology Landscape Metropolitan Dermatology has taken a strategic step by opening a new location right in the heart of Barnegat, New Jersey. Talk about a win-win for the folks in Ocean County. This isn't just another clinic opening up shop; it's about bringing comprehensive medical and surgical dermatologic care straight to the people who need...

Continue Reading

Top 5 Most Recently Viewed Articles

Armstrong Company Sees Leadership Shake-Up for Growth

Updated Category News Views 254

New Leadership at The Armstrong Company It’s about time. Armstrong’s rolling out fresh faces in the top spots. Todd Watson’s stepping down as CEO, but don’t get it twisted—he’s not leaving the building; he’s now co-chair along with his cousin Mark Pickens. These guys are the latest entries in a long line of leadership dating back to their founders in 1957....

Continue Reading
NVIDIA Prepares for Q3 Financial Results Conference

Updated Category News Views 194

NVIDIA's Upcoming Conference Call for Financial Results NVIDIA is gearing up to connect with stakeholders through a conference call planned for a future date. This call will focus on discussing the financial results for the company's third quarter of the current fiscal year. Investors and analysts will have the opportunity to gain insights into the financial landscape of...

Continue Reading
Free Heart and Kidney Health Screenings Set for January in Seattle

Updated Category News Views 268

Free Heart and Kidney Health Screenings in Seattle Residents of Seattle have a valuable opportunity coming up with the Heart & Kidney Health Screening initiative offered by Care Access. This program aims to enhance awareness of crucial health risk factors, particularly the dangerous lipoprotein(a), often abbreviated as Lp(a). Affecting one in five individuals, high Lp(a)...

Continue Reading
Important Legal Notification for Replimune Group Investors

Updated Category News Views 170

Protect Your Investment with Legal Guidance In the fast-paced world of investing, timely information is crucial for making informed decisions. This is especially true for investors in Replimune Group, Inc. (NASDAQ: REPL) who have participated in transactions within recent class periods. Understanding your rights and options can significantly affect your financial future....

Continue Reading
Class Action Alert: Kyverna Therapeutics Investors Take Note

Updated Category News Views 110

Important Opportunity for Kyverna Therapeutics, Inc. Investors Kyverna Therapeutics, Inc. (NASDAQ: KYTX) provides a significant opportunity for its shareholders due to a potential class action lawsuit concerning possible securities fraud. If you're someone who purchased common stock during the company’s initial public offering (IPO), you might be entitled to...

Continue Reading